Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorO'Hare, Bernadette Ann-Marie
dc.contributor.authorMilner, Jr, Danny A.
dc.contributor.authorNewberry, Laura
dc.contributor.authorPelani, Isaac
dc.contributor.authorMalista, Ken
dc.date.accessioned2015-07-20T16:10:02Z
dc.date.available2015-07-20T16:10:02Z
dc.date.issued2014-09-22
dc.identifier.citationO'Hare , B A-M , Milner, Jr , D A , Newberry , L , Pelani , I & Malista , K 2014 , ' Discordance between clinical and immunological ART eligibility criteria for children in Malawi ' , BMC Research Notes , vol. 7 , 666 . https://doi.org/10.1186/1756-0500-7-666en
dc.identifier.otherPURE: 150311803
dc.identifier.otherPURE UUID: ed60b1df-e792-4f03-9f54-f389d21cc068
dc.identifier.otherScopus: 84908010891
dc.identifier.otherORCID: /0000-0003-1730-7941/work/27345666
dc.identifier.urihttp://hdl.handle.net/10023/7002
dc.description.abstractBackground Since May 2014, all HIV positive children aged less than five years in Malawi are eligible for ART. For children older than five years they are eligible if they are in WHO stage III/IV, if stage I/II, if their CD4 < 500 cells/mm3. Our goal was to compare the WHO clinical classification criteria (WHO stage + CD4/age) to CD4 count (CD4/age) on all children. Prior to 2014, children aged 2-5 years in stage I and II were eligible for ART if their CD4 was < 750 cells/mm3. We were interested in the increase in children in this age group who now met the eligibility criteria and their average CD4 count. Methods Data including age, stage and CD4 count were used. We examined the effect of using two different criteria; WHO staging and checking CD4 count if stage I or II versus CD4 count on all, on the numbers of children eligibility for ART in a cohort of 969 children aged 0 to 14 years in Blantyre, Malawi. Results Using WHO stage + CD4/age, 786 patients out of 969 would have been treated and 183 would not. Using CD4/age, 745 patients out of 969 would have been treated and 224 would not. Within the 224 patients not treated by CD4 classification, 41 were clinical stage III or IV. The most common staging condition in these 41 children was low weight for age (i.e. underweight). 41% of children age2-5 years have a CD4 count >750. Conclusion Most children are correctly started on treatment using recent guidelines. 41% more children <5 years will be started on ART.
dc.format.extent6
dc.language.isoeng
dc.relation.ispartofBMC Research Notesen
dc.rights© 2014 O’Hare et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.en
dc.subjectHIV treatmenten
dc.subjectPediatricsen
dc.subjectAfricaen
dc.subjectMalawien
dc.subjectCD4 counten
dc.subjectWHO clinical stagingen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleDiscordance between clinical and immunological ART eligibility criteria for children in Malawien
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews.School of Medicineen
dc.contributor.institutionUniversity of St Andrews.Global Health Implementation Groupen
dc.identifier.doihttps://doi.org/10.1186/1756-0500-7-666
dc.description.statusPeer revieweden
dc.identifier.urlhttp://www.biomedcentral.com/1756-0500/7/666/abstracten


This item appears in the following Collection(s)

Show simple item record